The currently available antiplatelet drugs target key steps of platelet activation including thromboxane A 2 synthesis, ADP-mediated signaling ... The new P2Y 12 antagonists, prasugrel and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback